Kiniksa Pharmaceuticals International, plc Shareholders' Equity
Kiniksa Pharmaceuticals International, plc (KNSA) had Shareholders' Equity of $605.69 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-04-28
- 2026-03-31: Stockholders' Equity Attributable to Parent $605.69M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $567.61M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $535.38M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $495.01M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-03-31 | $605.69M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $567.61M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $535.38M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $495.01M 10-Q · filed 2025-10-28 |
| 2025-03-31 | $457.49M 10-Q · filed 2026-04-28 |
| 2024-12-31 | $438.44M 10-Q · filed 2026-04-28 |
| 2024-09-30 | $437.01M 10-Q · filed 2025-10-28 |
| 2024-06-30 | $435.10M 10-Q · filed 2025-10-28 |
| 2024-03-31 | $431.89M 10-Q · filed 2025-10-28 |
| 2023-12-31 | $438.84M 10-K · filed 2026-02-24 |
| 2023-09-30 | $405.13M 10-Q · filed 2024-10-29 |
| 2023-06-30 | $411.66M 10-Q · filed 2024-10-29 |
| 2023-03-31 | $390.10M 10-Q · filed 2024-10-29 |
| 2022-12-31 | $396.15M 10-K · filed 2026-02-24 |
| 2022-09-30 | $384.01M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $153.49M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $166.24M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $185.04M 10-K · filed 2025-02-25 |
| 2021-09-30 | $214.05M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $235.78M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $270.70M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $311.94M 10-K · filed 2024-02-28 |
| 2020-09-30 | $358.51M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $250.42M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $205.83M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $225.42M 10-K · filed 2023-03-02 |
| 2019-09-30 | $251.91M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $275.20M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $306.52M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $279.27M 10-K · filed 2022-02-24 |
| 2018-09-30 | $318.91M 10-Q · filed 2019-11-05 |
| 2018-06-30 | $341.80M 10-Q · filed 2019-11-05 |
| 2018-03-31 | -$105.11M 10-Q · filed 2019-11-05 |
| 2017-12-31 | -$89.71M 10-K · filed 2021-02-25 |
| 2016-12-31 | -$25.73M 10-K · filed 2019-03-12 |